Targeted oncogenesis in the thyroid of transgenic mice, J. Feunteun et al; protein kinase C alpha and tumorigenesis of the endocrine gland, C. Prevostel et al; origin and progression of thyroid epithelial tumors - cellular and molecular mechanisms, D. Wynford-Thomas; clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia, J. Leclere et al; targetting medullary thyroid carcinomas with bispecific antibodies and bivalent haptens, E. Rouvier et al; RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma, D.J. Marsh et al; multiple endocrine neoplasia type 1 and the search for the genetic trigger, F. Farnebo et al; tumor suppressor genes in the pathogenesis of human pituitary tumors, R.N. Clayton et al; molecular mechansism of parathyroid hyperplasia and neoplasia, M.L. Brandi; genetic testing in presymptomatic diagnosis of multiple endocrine neoplasia, A. Calender et al; management of patients and subjects at risk for multiple endocrine neoplasia type 1 - MEN 1, P. Chanson et al; multiple endocrine neoplasia type 2 - management of patients and subjects at risk, B. Conte-Devolx et al; abnormal transduction mechanisms in pituitary adenomas, A. Barlier et al; cyclic AMP and calcium in the transduction of hypothalamic neurohormone action in human pituitary tumors, A. Spada et al; nerve growth factor suppresses the tumoral phenotype of human prolactinomas, C. Missale et al; effects of the cAMP pathway activation in somatotrophs, J. Bertherat; pit-1 gene expression in human pituitary adenomas, I. Pellegrini-Bouiller et al; V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors, Y. de Keyzer et al; genetic alterations of the RET proto-oncogene in familial and sporadic phenochromocytomas, P. Rodien et al; molecular markers for malignancy in andrenocortical tumors, C. Gicquel and Y. LeBouc; adrenocorticotropin receptor and adrenal disorders, B. Allolio and M. Reincke; adrenal incidentaloma - an overview of clinical and epidemiological data from the National Italian Study Group, A. Angeli et al; adrenal incidentaloma - an overview of hormonal data from the National Italian Study Group, F. Mantero et al.
